Theratechnologies Inc THTX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 06/11/21 EDT
3.54quote price arrow up+0.02 (+0.57%)
Volume
53,952
52 week range
1.76 - 4.25

...

Loading . . .
  • Open3.54
  • Day High3.54
  • Day Low3.50
  • Prev Close3.52
  • 52 Week High4.25
  • 52 Week High Date04/13/21
  • 52 Week Low1.76
  • 52 Week Low Date06/12/20

Key Stats

  • Market Cap332.66M
  • Shares Out93.84M
  • 10 Day Average Volume0.08M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change41.6

KEY STATS

  • Open3.54
  • Day High3.54
  • Day Low3.50
  • Prev Close3.52
  • 52 Week High4.25
  • 52 Week High Date04/13/21
  • 52 Week Low1.76
  • 52 Week Low Date06/12/20
  • Market Cap332.66M
  • Shares Out93.84M
  • 10 Day Average Volume0.08M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change41.6

RATIOS/PROFITABILITY

  • EPS (TTM)-0.31
  • P/E (TTM)-11.60
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date07/13/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Theratechnologies Inc

There is no recent news for this security.

Latest From Our Partners

Profile

MORE
Theratechnologies Inc is a Canada-based specialty pharmaceutical company. The Company addresses medical needs to promote healthy living for human immunodeficiency virus (HIV) patients. Its products include EGRIFTA and Ibalizumab. EGRIFTA (tesamorelin for injection) refers to tesamorelin and it is indicated for the reduction of excess abdominal fat in HIV infected patients with lipodystrophy. EGRIFTA is indicated for the treatment of excess visceral adipose tissue (VAT), as...
Dawn Svoronos
Chairman
Paul Levesque
President
Philippe Dubuc
Chief Financial Officer
Andre Dupras
Vice President
Jocelyn Lafond
Vice President
Marie-Noel Colussi
Vice President - Finance
Address
1100-2015 RUE Peel
Montreal, QC
H3A 1T8
Canada